Peng and colleagues demonstrated that the expression of NKp30 and NKp46 correlated with pathological stage and histological grade in patients with PDAC, as well as GC and CRC (see below), which indicates that NK cell dysfunction may participate in malignant progression in these tumor types. This evidence concerns the gene NCR3 and colorectal carcinoma.